Furthermore, three target genes of bile acid metabolism (FN1, COL1A1 and MMP9) were strongly associated with the clinical stage and prognosis of patients with COAD, with high specificity regarding immune cell infiltration. This evidence concerns the gene COL1A1 and colon adenocarcinoma.